NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
- Not stated
- Not stated
- May 28, 2026
Official announcement on nih_guide+grants_gov · opens the funder's page. Always confirm dates there.
Summary
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs (also known as America's Seed Fund) are major sources of early-stage funding for U.S. technology development and commercialization. […]
Other topics in this solicitation
NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed)
NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed)
NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed)
Institutional Mentored Career Development Award (Parent K12) (Clinical Trials Not Allowed)
Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
The rest of this announcement — free with an account
- The full announcement text, not the first two sentences
- All 7 review criteria reviewers score this against, extracted from this announcement
- Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
- What similar funded projects received, from 219,000 past awards
More from National Institutes of Health
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
$250k
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
$350k